Danimer Scientific Management

Management criteria checks 3/4

Danimer Scientific's CEO ist Stephen Croskrey , ernannt in Feb 2016, hat eine Amtszeit von 8.08 Jahren. Die jährliche Gesamtvergütung beträgt $6.81M , bestehend aus 12.9% Gehalt und 87.1% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 4.21% der Aktien des Unternehmens, im Wert von $5.76M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5 Jahre bzw. 4 Jahre.

Key information

Stephen Croskrey

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage	26.1%
CEO tenure	8.2yrs
CEO ownership	4.0%
Management average tenure	5.1yrs
Board average tenure	4.1yrs

Recent management updates

Recent updates

Danimer Scientific Is In Trouble

Nov 17

Danimer Scientific: It's Not Time To Buy

Sep 05

Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream

Jun 20

Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

May 15

Danimer Scientific: Falling Momentum As Cash Burn Climbs

Dec 19

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Nov 17

Danimer Scientific: Biodegradable Plastics Are Still Important

Sep 30

Danimer Scientific stock slides on $100M securities offering

Aug 26

These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat

Aug 17

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Nov 25

Danimer Scientific: Prepare For Takeoff

Aug 19

Danimer Scientific Momentarily Stumbles In Mission To Produce Biodegradable Plastics

Jun 04

Danimer Scientific drops after Spruce Point issued another short report

May 04

CEO Compensation Analysis

How has Stephen Croskrey's remuneration changed compared to Danimer Scientific's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$3m	US$875k	-US$155m
Sep 30 2023	n/a	n/a	-US$144m
Jun 30 2023	n/a	n/a	-US$199m
Mar 31 2023	n/a	n/a	-US$190m
Dec 31 2022	US$7m	US$875k	-US$180m
Sep 30 2022	n/a	n/a	-US$164m
Jun 30 2022	n/a	n/a	-US$61m
Mar 31 2022	n/a	n/a	US$8m
Dec 31 2021	US$72m	US$875k	-US$60m
Sep 30 2021	n/a	n/a	-US$51m
Jun 30 2021	n/a	n/a	-US$61m
Mar 31 2021	n/a	n/a	-US$102m
Dec 31 2020	US$29m	US$424k	-US$9m
Sep 30 2020	n/a	n/a	-US$9m
Jun 30 2020	n/a	n/a	-US$3m
Mar 31 2020	n/a	n/a	-US$11m
Dec 31 2019	US$6m	US$394k	-US$20m

Vergütung im Vergleich zum Markt: StephenDie Gesamtvergütung ($USD6.81M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD738.70K).

Entschädigung vs. Einkommen: StephenDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

CEO

Stephen Croskrey (62 yo)

8.2yrs

Tenure

US$3,356,595

Compensation

Mr. Stephen E. Croskrey has been the Chief Executive Officer and Director of Danimer Scientific, Inc. since February 2016 and serves as its Chairman of the Board since December 2020. Mr. Croskrey was Legac...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Stephen Croskrey	CEO & Chairman of the Board	8.2yrs	US$3.36m	3.98% $ 4.8m
Michael Hajost	Chief Financial Officer	2.1yrs	US$822.61k	0.073% $ 87.3k
Scott Tuten	Chief Marketing & Sustainability Officer	10.3yrs	US$334.12k	0.17% $ 204.2k
Michael Smith	Chief Operating Officer	17.3yrs	US$14.27m	0.091% $ 108.6k
Russ Zukowski	Vice President of Corporate Finance	no data	no data	no data
Phillip Van Trump	Chief Science & Technology Officer	10.3yrs	US$338.50k	0.13% $ 154.1k
James Palczynski	Investor Relations Officer	no data	no data	no data
Stephen Martin	Corporate Secretary & Chief Legal Officer	1.6yrs	no data	no data
Anthony Austin	Chief Human Resource Officer	2yrs	no data	no data
John Dowdy	Senior Vice President of Financial Planning & Analysis	2.1yrs	US$14.27m	0% $ 0

5.1yrs

Average Tenure

54yo

Average Age

Erfahrenes Management: Das Managementteam von DNMR ist erfahren und erfahren (durchschnittliche Amtszeit: 5 Jahre).

Board Members

Name	Position	Tenure	Compensation	Ownership
Stephen Croskrey	CEO & Chairman of the Board	8.2yrs	US$3.36m	3.98% $ 4.8m
John Amboian	Lead Independent Director	3.3yrs	US$130.00k	0.56% $ 671.1k
Cynthia Cohen	Independent Director	1.7yrs	US$105.00k	0% $ 0
Gregory Hunt	Independent Director	4.8yrs	US$120.00k	0% $ 0
Richard Hendrix	Independent Director	3.3yrs	US$105.00k	0.39% $ 463.4k
Phillip Calhoun	Independent Director	10.3yrs	US$100.00k	3.31% $ 4.0m
Allison Leopold Tilley	Independent Director	1.7yrs	US$100.00k	0% $ 0
Stuart Pratt	Director	8.9yrs	US$116.00k	1.26% $ 1.5m
Isao Noda	Independent Director	8.3yrs	US$100.00k	0.0040% $ 4.8k
David Moody	Independent Director	less than a year	no data	no data

4.1yrs

Average Tenure

62yo

Average Age

Erfahrener Vorstand: DNMRDie Vorstandsmitglieder gelten als erfahren (4.5 Jahre durchschnittliche Amtszeit).

Danimer Scientific Management

Management criteria checks 3/4

Key information

Recent management updates

Danimer Scientific, Inc. Announces New Directors

Independent Director recently bought US$93k worth of stock

Chief Financial Officer exercised options and sold US$61k worth of stock

Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

Director recently sold US$873k worth of stock

Insider notifies of intention to sell stock

Recent updates

Consensus revenue estimates decrease by 25%, EPS upgraded

Price target decreased by 14% to US$2.22

Full year 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million.

New minor risk - Shareholder dilution

Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million.

New major risk - Share price stability

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Danimer Scientific, Inc. Announces New Directors

Independent Director recently bought US$93k worth of stock

New minor risk - Market cap size

Consensus revenue estimates fall by 21%

Price target decreased by 11% to US$4.20

Danimer Scientific Is In Trouble

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Danimer Scientific, BIOLO and Bolthouse Farms Announce Commercialization of Home Compostable Packaging for Fresh Produce with Meijer Stores

Danimer Scientific: It's Not Time To Buy

Price target decreased by 13% to US$4.60

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q2, 2023 Results on Aug 08, 2023

New major risk - Financial position

Price target decreased by 8.8% to US$5.30

Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream

Consensus revenue estimates fall by 16%

Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Danimer Scientific, Inc. to Report Q1, 2023 Results on May 10, 2023

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer exercised options and sold US$61k worth of stock

Danimer Scientific: Falling Momentum As Cash Burn Climbs

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Price target decreased to US$6.13

Price target decreased to US$6.13

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022

Danimer Scientific, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Danimer Scientific: Biodegradable Plastics Are Still Important

Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

Danimer Scientific stock slides on $100M securities offering

Director recently sold US$873k worth of stock

Insider notifies of intention to sell stock

These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat

Danimer Scientific, Inc. Elects Board Members

Consensus revenue estimates fall by 47%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Investor sentiment deteriorated over the past week

Insider notifies of intention to sell stock

Investor sentiment improved over the past week

Danimer Scientific, Inc., Annual General Meeting, Aug 11, 2022

Danimer Scientific, Inc.(NYSE:DNMR) dropped from Russell 2000 Growth Index

Investor sentiment improved over the past week

Danimer Scientific: Bright Future But Currently A Murky Investment Case

Price target decreased to US$9.17

Danimer Scientific, Inc. Provides Earnings Guidance for the Year 2022

Danimer Scientific, Inc. Appoints Anthony Austin as Chief Human Resource Officer

Danimer Scientific: An Innovative Bioplastics Player With Huge Upside Potential

Danimer Scientific, Inc. announced delayed annual 10-K filing

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q4, 2021 Results on Feb 28, 2022

Danimer Scientific: Growth Opportunities Will Promote Its Stock Price

Consensus forecasts updated

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Insider exercised options and sold US$123k worth of stock

Price target decreased to US$27.00

Third quarter 2021 earnings released: EPS US$0.08 (vs US$0.66 loss in 3Q 2020)